Edgestream Partners’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-16,469
Closed -$9.25M 1052
2026
Q1
$9.25M Buy
16,469
+14,244
+640% +$9.13M 0.3% 60
2025
Q4
$1.51M Buy
2,225
+1,334
+150% +$908K 0.04% 601
2025
Q3
$569K Sell
891
-1,864
-68% -$1.13M 0.02% 713
2025
Q2
$1.48M Sell
2,755
-18,507
-87% -$8.85M 0.04% 582
2025
Q1
$8.93M Buy
21,262
+2,849
+15% +$1.24M 0.3% 55
2024
Q4
$7.61M Buy
18,413
+17,176
+1,389% +$7.53M 0.32% 46
2024
Q3
$625K Sell
1,237
-8,340
-87% -$4.05M 0.03% 663
2024
Q2
$4.67M Buy
9,577
+7,542
+371% +$3.79M 0.22% 143
2024
Q1
$1.1M Buy
2,035
+1,129
+125% +$617K 0.05% 475
2023
Q4
$503K Buy
+906
New +$425K 0.04% 615
2023
Q3
Sell
-583
Closed -$293K 882
2023
Q2
$293K Sell
583
-2,007
-77% -$962K 0.03% 635
2023
Q1
$1.3M Buy
2,590
+604
+30% +$289K 0.14% 236
2022
Q4
$810K Buy
+1,986
New +$771K 0.09% 287
2021
Q4
Sell
-5,783
Closed -$3.6M 522
2021
Q3
$3.6M Buy
+5,783
New +$3.89M 0.22% 160

Other funds holding IDXX

Edgestream Partners's IDXX Position: Q2 2026 in Review

Edgestream Partners sold out of Idexx Laboratories (IDXX) in Q2 2026, closing a stake of 16,469 shares — an estimated $9.25M sold.

Edgestream Partners first reported a position in IDXX in Q3 2021 and held it in 14 quarters. The position peaked at $9.25M in Q1 2026. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Edgestream Partners reported no remaining Idexx Laboratories position as of Q2 2026 after selling out during the quarter.
  • Edgestream Partners sold 16,469 Idexx Laboratories shares in Q2 2026, an estimated $9.25M.
  • Edgestream Partners first reported a position in Idexx Laboratories in Q3 2021 and held it in 14 quarters.
  • Edgestream Partners's Idexx Laboratories position peaked at $9.25M in Q1 2026.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Edgestream Partners's 13F filing for Q2 2026, filed 11 Aug 2026.